Glucocorticoids for ARDS: Just Do It!

PubWeight™: 1.21‹?› | Rank: Top 10%

🔗 View Article (PMID 17426190)

Published in Chest on April 01, 2007

Authors

Djillali Annane

Articles by these authors

(truncated to the top 100)

Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med (2013) 39.56

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med (2013) 17.37

Hydrocortisone therapy for patients with septic shock. N Engl J Med (2008) 15.85

Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med (2008) 5.30

A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med (2009) 4.13

Fluid resuscitation in sepsis: a systematic review and network meta-analysis. Ann Intern Med (2014) 3.96

Corticosteroid treatment and intensive insulin therapy for septic shock in adults: a randomized controlled trial. JAMA (2010) 3.50

The effects of etomidate on adrenal responsiveness and mortality in patients with septic shock. Intensive Care Med (2009) 3.30

Clinical practice guideline on diagnosis and treatment of hyponatraemia. Eur J Endocrinol (2014) 3.06

Clinical and electrophysiological predictors of respiratory failure in Guillain-Barré syndrome: a prospective study. Lancet Neurol (2006) 2.50

Practice parameters for hemodynamic support of sepsis in adult patients: 2004 update. Crit Care Med (2004) 2.33

ICU physicians should abandon the use of etomidate! Intensive Care Med (2005) 2.32

Outcome of acute mesenteric ischemia in the intensive care unit: a retrospective, multicenter study of 780 cases. Intensive Care Med (2015) 2.25

Circulating vasopressin levels in septic shock. Crit Care Med (2003) 2.22

Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant (2014) 2.10

Decompression sickness in urban divers in France. Int Marit Health (2012) 1.98

Immunotherapy for Guillain-Barré syndrome: a systematic review. Brain (2007) 1.87

Adrenal function in sepsis: the retrospective Corticus cohort study. Crit Care Med (2007) 1.74

Sepsis-associated delirium. Intensive Care Med (2007) 1.72

Brain lesions in septic shock: a magnetic resonance imaging study. Intensive Care Med (2007) 1.69

Diabetic status and the relation of the three domains of glycemic control to mortality in critically ill patients: an international multicenter cohort study. Crit Care (2013) 1.66

Compartmentalization of the inflammatory response in sepsis and SIRS. J Endotoxin Res (2006) 1.66

Cardiovascular response to dopamine and early prediction of outcome in septic shock: a prospective multiple-center study. Crit Care Med (2005) 1.63

A balanced view of balanced solutions. Crit Care (2010) 1.61

Guillain-Barré syndrome following primary cytomegalovirus infection: a prospective cohort study. Clin Infect Dis (2011) 1.60

Brainstem responses can predict death and delirium in sedated patients in intensive care unit. Crit Care Med (2011) 1.59

Hydrocortisone effects on cardiovascular variability in septic shock: a spectral analysis approach. Crit Care Med (2008) 1.54

The neuropathology of septic shock. Brain Pathol (2004) 1.53

Osmoregulation of vasopressin secretion is altered in the postacute phase of septic shock. Crit Care Med (2010) 1.53

Reducing mortality in sepsis: new directions. Crit Care (2002) 1.52

StO₂ guided early resuscitation in subjects with severe sepsis or septic shock: a pilot randomised trial. J Clin Monit Comput (2013) 1.51

The highs and lows of intensive insulin therapy. Am J Respir Crit Care Med (2006) 1.47

Treatment of osteoradionecrosis of the jaw: the case against the use of hyperbaric oxygen. J Oral Maxillofac Surg (2010) 1.45

Masseter tissue oxygen saturation predicts normal central venous oxygen saturation during early goal-directed therapy and predicts mortality in patients with severe sepsis. Crit Care Med (2012) 1.45

The absence of adrenal gland enlargement during septic shock predicts mortality: a computed tomography study of 239 patients. Anesthesiology (2011) 1.44

Neuropathological Correlates of Hyperglycemia During Prolonged Polymicrobial Sepsis in Mice. Shock (2015) 1.43

Steroid treatment in ARDS: a critical appraisal of the ARDS network trial and the recent literature. Intensive Care Med (2007) 1.36

Successful long-term treatment of hyponatremia in syndrome of inappropriate antidiuretic hormone secretion with satavaptan (SR121463B), an orally active nonpeptide vasopressin V2-receptor antagonist. Clin J Am Soc Nephrol (2006) 1.32

Activation and regulation of systemic inflammation in ARDS: rationale for prolonged glucocorticoid therapy. Chest (2009) 1.32

Long-term outcome of iatrogenic gas embolism. Intensive Care Med (2010) 1.28

Apoptosis of neurons in cardiovascular autonomic centres triggered by inducible nitric oxide synthase after death from septic shock. Lancet (2003) 1.28

Plasma exchange for Guillain-Barré syndrome. Cochrane Database Syst Rev (2012) 1.25

Dynamic data during hypotensive episode improves mortality predictions among patients with sepsis and hypotension. Crit Care Med (2013) 1.24

Vasopressin for treatment of vasodilatory shock: an ESICM systematic review and meta-analysis. Intensive Care Med (2011) 1.22

Bench-to-bedside review: Beta-adrenergic modulation in sepsis. Crit Care (2009) 1.18

Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intensive Care Med (2014) 1.17

Whole-body muscle MRI in 20 patients suffering from late onset Pompe disease: Involvement patterns. Neuromuscul Disord (2011) 1.16

Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med (2017) 1.15

Science review: The brain in sepsis--culprit and victim. Crit Care (2004) 1.11

Clinical review: corticotherapy in sepsis. Crit Care (2003) 1.11

Cardiac and respiratory effects of continuous positive airway pressure and noninvasive ventilation in acute cardiac pulmonary edema. Crit Care Med (2002) 1.08

Effects of high doses of selenium, as sodium selenite, in septic shock: a placebo-controlled, randomized, double-blind, phase II study. Crit Care (2007) 1.08

Automatic air-leak compensation in neuromuscular patients: a feasibility study. Respir Med (2008) 1.07

Mortality of patients with heatstroke admitted to intensive care units during the 2003 heat wave in France: a national multiple-center risk-factor study. Crit Care Med (2006) 1.07

Understanding brain dysfunction in sepsis. Ann Intensive Care (2013) 1.06

Guillain-Barré syndrome and influenza virus infection. Clin Infect Dis (2009) 1.05

Cardiomyopathy in Duchenne muscular dystrophy: pathogenesis and therapeutics. Heart Fail Rev (2010) 1.05

The encephalopathy in sepsis. Crit Care Clin (2008) 1.03

Risk of death does not alter the efficacy of hydrocortisone therapy in a mouse E. coli pneumonia model: risk and corticosteroids in sepsis. Intensive Care Med (2007) 1.02

Glucocorticoid treatment in acute lung injury and acute respiratory distress syndrome. Crit Care Clin (2011) 1.01

Dissociation of serum dehydroepiandrosterone and dehydroepiandrosterone sulfate in septic shock. J Clin Endocrinol Metab (2006) 1.01

Effects of esmolol on systemic and pulmonary hemodynamics and on oxygenation in pigs with hypodynamic endotoxin shock. Intensive Care Med (2011) 0.99

Multifocal necrotizing leukoencephalopathy in septic shock. Crit Care Med (2002) 0.99

Corticosteroid insufficiency in acutely ill patients. N Engl J Med (2003) 0.98

Recombinant human acid alpha-glucosidase (rhGAA) in adult patients with severe respiratory failure due to Pompe disease. Neuromuscul Disord (2011) 0.96

Health-related quality of life in family members of intensive care unit patients. J Palliat Med (2010) 0.96

Relative adrenal failure in the ICU: an identifiable problem requiring treatment. Crit Care Clin (2006) 0.94

Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev (2013) 0.93

Physiological effects of decannulation in tracheostomized patients. Intensive Care Med (2002) 0.93

Modafinil for the treatment of hypersomnia associated with myotonic muscular dystrophy in adults: a multicenter, prospective, randomized, double-blind, placebo-controlled, 4-week trial. Clin Ther (2009) 0.92

Prolonged glucocorticoid treatment in acute respiratory distress syndrome: Evidence supporting effectiveness and safety. Crit Care Med (2009) 0.92

Critical illness-induced dysglycemia and the brain. Intensive Care Med (2014) 0.91

Year in review 2010: Critical Care--Multiple organ dysfunction and sepsis. Crit Care (2011) 0.91

Bedside adherence to clinical practice guidelines in the intensive care unit: the TECLA study. Intensive Care Med (2008) 0.91

Clinical research ethics for critically ill patients: a pandemic proposal. Crit Care Med (2010) 0.91

Prognosis and risk factors of early onset pneumonia in ventilated patients with Guillain-Barré syndrome. Intensive Care Med (2006) 0.91

Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids. Crit Care (2004) 0.91

Reduced cortisol metabolism during critical illness. N Engl J Med (2013) 0.91

Cost-effectiveness of activated protein C in real-life clinical practice. Crit Care (2007) 0.91

Supine volume drop and diaphragmatic function in adults with Pompe disease. Eur Respir J (2012) 0.91

Metabolism modulators in sepsis: the abnormal pituitary response. Crit Care Med (2007) 0.90

Pro: the illegitimate crusade against corticosteroids for severe H1N1 pneumonia. Am J Respir Crit Care Med (2011) 0.89

Multicenter comparison of cortisol as measured by different methods in samples of patients with septic shock. Intensive Care Med (2009) 0.88

Adrenal insufficiency in septic shock. Clin Chest Med (2009) 0.86

The use of corticosteroids in severe sepsis and acute respiratory distress syndrome. Ann Med (2002) 0.86

Corticosteroids in ARDS: a counterpoint. Chest (2007) 0.86

Pacemaker implantation for sinus node dysfunction in a young patient with Duchenne muscular dystrophy. Congest Heart Fail (2010) 0.85

Early-onset ventilator-associated pneumonia in adults randomized clinical trial: comparison of 8 versus 15 days of antibiotic treatment. PLoS One (2012) 0.85

Pattern of brain injury in the acute setting of human septic shock. Crit Care (2013) 0.85

Middle-ear barotrauma after hyperbaric oxygen therapy. Undersea Hyperb Med (2010) 0.84

Corticoids normalize leukocyte production of macrophage migration inhibitory factor in septic shock. J Infect Dis (2004) 0.84

Hippocampus: a future target for sepsis treatment! Intensive Care Med (2009) 0.84

Impact of hyperglycemia on neuropathological alterations during critical illness. J Clin Endocrinol Metab (2012) 0.83

Thirty years of critical care medicine. Crit Care (2010) 0.83

Mechanical ventilation for amyotrophic lateral sclerosis/motor neuron disease. Cochrane Database Syst Rev (2009) 0.82

Effect of a tracheostomy speaking valve on breathing-swallowing interaction. Intensive Care Med (2011) 0.82

Pathophysiology of acute respiratory distress syndrome. Glucocorticoid receptor-mediated regulation of inflammation and response to prolonged glucocorticoid treatment. Presse Med (2011) 0.82

Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome. J Clin Microbiol (2010) 0.81

Hyperglycaemia and apoptosis of microglial cells in human septic shock. Crit Care (2011) 0.81

Mechanisms of brain signaling during sepsis. Curr Neuropharmacol (2009) 0.81